Genetics of pediatric central nervous system tumors

Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 6, 1997, Pages 492-501

  Biegel, Jaclyn A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Astrocytoma; Chromosome 17; Chromosome 22; Medulloblastoma; Primitive neuroectodermal tumor; Rhabdoid tumor; Tumor suppressor gene

Indexed keywords

ASTROCYTOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CHROMOSOME 17P; CHROMOSOME 22Q; CYTOGENETICS; EPENDYMOMA; FAMILIAL CANCER; GENE MUTATION; GERM CELL TUMOR; GLIOMA; HUMAN; MENINGIOMA; NEUROECTODERM TUMOR; NEUROFIBROMATOSIS; PRIORITY JOURNAL; REVIEW; RHABDOID TUMOR; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

ADULT; BRAIN NEOPLASMS; CHILD; HUMANS; MOLECULAR BIOLOGY;

EID: 0031416280     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199711000-00002     Document Type: Review

References (79)

1. Cawthon R, White R. Neurofibromatosis I. In: Levine AJ, Schmidek HH (eds). Molecular Genetics of Nervous System Tumors. New York: John Wiley & Sons, Inc. 1993:329-40.
2. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel Moesin-, Ezrin-, Radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.
3. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-21.
4. MacCollin M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 1994;55:314-20.
5. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence of the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 1994;6:180-4.
6. Frebourg T, Friend SH. Cancer risks from germline P53 mutations. J Clin Invest 1992;90:1637-41.
7. Chung R, Whaley J, Kley N, et al. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer 1991;3:323-31.
8. Fink KL, Rushing EJ, Schold SC, Jr. et al. Infrequency of p53 gene mutations in ependymomas. J Neurooncol 1996; 27:111-5.
9. Saylors RL, Sidransky D, Friedman HS, et al. Infrequent p53 gene mutations in medulloblastomas. Cancer Res 1991;51:4721-3.
10. Raffel C, Thomas GA, Tishler DM, et al. Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 1993;33:301-6.
11. Felix CA, Slavc I, Dunn M, et al. Germline and somatic p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 1995; 25:431-6.
12. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
13. Fryer AE, Chalmers A, Connor JM, et al. Evidence that the gene tor tuberous sclerosis is on chromosome 9. Lancet 1987;1:659-61.
14. Kandt RS, Haines JL, Smith M. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nature Genet 1992;2:37-41.
15. Sepp T, Yates JRW, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996;33:962-4.
16. The European Chromosome 16 Tuberous Sclerosis Consortium: Identification of the tuberous sclerosis gene on chromosome 16. Cell 1993;5:1305-15.
17. Xiao GH, Shoarinejad F, Jin F, et al. The tuberous sclerosis-2 gene-product, tuberin, functions as a RAB5 GTPase-activating-protein (GAP) in modulating endocytosis. J Biol Chem 1997;272:6097-6100.
18. Rorke LB, Trojanowski JQ, Lee VM-Y, et al. Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 1997;7:765-87.
19. Biegel JA, Rorke LB, Packer RJ, et al. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1989;1:139-47.
20. Scheurlen WG, Krauss J, Kuhl J, et al. No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma. Int J Cancer 1995;63:373-4.
21. Biegel JA, Wentz E. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor-medulloblastoma. Genes Chromosomes Cancer 1997;18:143-6.
22. Batra SK, McLendon RE, Koo JK, et al. Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 1995;24:39-45.
23. Coaen PH, McDonald JD. Tumor suppressor genes and medulloblastoma. J Neurooncol 1996;29:103-12.
24. Biegel JA, Janss AJ, Raffel C et al. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clinical Cancer Research 1997;3:473-8.
25. Biegel JA, Burk CD, Barr FG, et al. Evidence for a 17p tumor related locus distinct from p53 in pediatric central nervous system primitive neuroectodermal tumors. Cancer Res 1992;52:3391-5.
26. Thomas GA, Raffel C. Loss of heterozygosity on 6q, 16q and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 1991;51:639-43.
27. Biegel JA, Rorke LB, Janss AJ, et al. Isochromosome 17q demonstrated by interphase FISH in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1995;14:85-96.
28. Wilgenbus KK, Seranski P, Brown A, et al. Molecular characterization of a genetically unstable region containing the SMS critical area and a breakpoint cluster for human PNETs. Genomics 1997;42:1-10.
29. Slave I, Rodriguez IR, Mazuruk K, et al. LOH detected by single strand conformation polymorphism analysis of PEDF in CNS primitive neuroectodermal tumors. Med Pediatr Oncol 1995;25:P174.
30. Gilbertson RJ, Pearson ADJ, Perry RH, et al. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer 1995;73:473-7.
31. Griffin CA, Hawkins AL, Packer RJ, et al. Chromosome abnormalities in pediatric brain tumors. Cancer Res 1988;48:175-80.
32. Neumann E, Kalousek DK, Norman MG, et al. Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 1993;71:40-9.
33. Sreekantaiah C, Jockin H, Brecher ML, et al. Interstitial deletion of chromosome 11q in a pineoblastoma. Cancer Genet Cytogenet 1989;39:125-31.
34. James CD, He J, Carlbom E, et al. Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromosomes Cancer 1990;2:94-102.
35. Vagner-Capodano AM, Center JC, Choux M, et al. Chromosomal abnormalities in 16 pediatric brain tumors. Pediatr Neurosci 1988;14:150-9.
36. Biegel JA, Rorke LB, Packer RJ, et al. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. J Neurosurg 1990;73:710-4.
37. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56-65.
38. Schutz BR, Scheurlen W, Krauss J, et al. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996;16:196-203.
39. Reardon DA, Michalkiewicz E, Sublett, et al. Characterization of the molecular abnormalities of childhood medulloblastoma using comparative genomic hybridization. Seventh International Symposium Pediatric Neuro-Oncology 1996 Abstract #8.
40. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299-308.
41. Evans DGR, Farndon PA, Burnell LD, et al. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991;64:959-61.
42. Hahn H, Wicking C, Zuphiropoulos PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51.
43. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for basal cell nevus syndrome. Science 1996;272:1668-71.
44. Hunter T. Oncoprotein networks. Cell 1997;88:333-46.
45. Oro AE, Higgis KM, Hu Z, et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 1997;276:817-21
46. Raffel C, Jenkins RB, Frederick L, et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1996;57:842-5.
47. Mori T, Nagase H, Horii A, et al. Germ-line and somatic mutations of the APC gene in patients with Turcot-syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer 1994;9:168-72.
48. Peifer M. b-catenin as oncogene: the smoking gun. Science 1997;275:1752-4.
49. Segal RA, Goumnerova LC, Kwon YK, et al. Expression of the neurotrophin receptor trkC linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 1994;91:2867-71.
50. Rostomily RC, Bermingham-McDonogh O, Berger MS, et al. Expression of neurogenic bHLH genes in neuroectodermal tumors. Cancer Res In press.
51. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
52. Bonnin JM, Rubinstein LJ, Palmer NF, et al. The association of embryonal tumors originating in the kidney and in the brain. Cancer 1984;54:2137-46.
53. Biegel JA, Allen CS, Kawasaki K, et al. Narrowing the critical region for a rhabdoid tumor locus in 22q11. Genes Chromosomes Cancer 1996;16:94-105.
54. Schofield DE, Beckwith JlB, Sklar J. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer 1996;15:10-7.
55. Karnes PS, Tran TN, Cui MY, et al. Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality. 46,XY,t(11;22) (p15.5;q11.23). Cancer Genet Cytogenet 1991;56:31-8.
56. Lee MP, Hu RJ, Johnson LA, et al. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Widemann syndrome chromosomal rearrangements. Nat Genet 1997;15:181-5.
57. Biegel JA, Parmiter AH, Sutton LN, et al. Abnormalities of chromosome 22 in pediatric meningiomas. Genes Chromosomes Cancer 1994;9:81-7.
58. Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982;6:249-74.
59. Ransom DT, Ritland SR, Kimmel DW, et al. Cytogenetic and loss of heterozygosity studies in ependyinomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 1992;5: 348-56.
60. Rubio MP, Correa KM, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994;54:45-57.
61. Slave I, MacCollin MM, Dunn M, et al. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 1995;64:243-7.
62. Watkins D, Ruttledge MH, Sarrazin J, et al. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type-2 gene. Cancer Genet Cytogenet 1996; 92:73-8.
63. Sutton LN, Goldwein J, Perilongo G, et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990-91;16:57-65.
64. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurg 1995;37:655-66.
65. Park JP, Chaffee S, Noll WW, et al. Constitutional de novo t(1:22)(p22;11.2) and ependymoma. Cancer Genet Cytogenet 1996;86:150-2.
66. Kramer DL, Parmiter AH, Rorke LB, et al. Molecular cytogenetic studies of ependymomas. J Neurooncol in press.
67. von Haken MS, White EC, Daneshvar-Shyesther L, et al. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 1996;17:37-44.
68. Brinster RI, Chen HY, Messing A, et al. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-79.
69. Bergsagel DJ, Finegold MJ, Butel JS, et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood N Engl J Med 1992;326:988-93.
70. Louis DN. A molecular genetic model of astrocytoma histopathology. Brain Pathol 1997;7:755-64.
71. Ichimura K, Schmidt EE, Goike HM, et al. Human glioblastomas with no alterations of the CDKN2A, P16(INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72.
72. Steck PA, Pershouse MA, Jasser SA, et al Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
73. Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997;275:1943-7.
74. Moscatello DK, Holgado-Madruga M, Godwin AK, et al. Frequent expression of a mutant EGF receptor in multiple human tumors. Cancer Res 1995;55:5536-9.
75. Pollack, I.F., Hamilton, R.L., Finkelstein, S.D et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 1997;57:304-9.
76. de Bruin TWA, Slater RM, Defferrari R, et al. Isochromosome 12p-positive pineal germ cell tumor. Cancer Res 1994;54:1542.
77. Shen V, Chapparo M, Choi BH, et al. Absence of isochromosome 12p in a pineal region malignant germ cell tumor. Cancer Genet Cytogenet 1990;50:153-60.
78. Yu IT, Griffin CA, Phillips PC, et al. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridization. Lab Invest 1995;72:419-23.
79. Perlman EJ, Valentine MB, Griffin CA, et al. Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study. Genes Chromosomes Cancer 1996;16:15-20.